PERSPECTIVES

The opportunity at EQRx is truly exciting: the time is now to engage patients, healthcare providers and policymakers to make innovative medicines at radically lower prices a reality for the benefit of all. I look forward to joining this team of healthcare veterans committed to reimagining medicine.

Bio

Richard Buckley is a public affairs and corporate communications expert with more than 20 years of worldwide government affairs and corporate communications experience within the pharmaceutical industry.

He most recently served as vice president of global corporate affairs at AstraZeneca and president of the AstraZeneca Healthcare Foundation. Over his 17-year tenure at AstraZeneca, Rich was responsible for reputation management, internal, external, scientific and product communications, as well as global government affairs and policy, patient advocacy and philanthropy. Before joining AstraZeneca, Rich was director of federal government affairs at Eli Lilly and Company, legislative counsel at PhRMA and an assistant parliamentarian in the United States Senate. He received his J.D. from American University Law School and his B.A. in political science from Boston College.

View All